KHAN , R. (2024) “DOCETAXEL VERSUS DOCETAXEL PLUS CAPECITABINE AS NEOADJUVANT CHEMOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER PATIENTS”, Biological and Clinical Sciences Research Journal. Lahore, PK, 2024(1), p. 654. doi: 10.54112/bcsrj.v2024i1.654.